PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24426F0063Radiopharmaceuticals-lutathera and pluvicto — Novartis Pharmaceuticals Corp

Novartis Pharmaceuticals Corp holds $23.5M across 59 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79720D0180. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Dec 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

244-Network Contract Office 4 (36C244)
Awarding office
Novartis Pharmaceuticals Corp
Recipient
Dec 31, 2026
PoP end
$2M
Obligated
$2M
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Novartis Pharmaceuticals Corp — $90

Contract facts

Federal
Contract number36C24426F0063
Also listed as36C244-26-F-0063
Also listed as36F79720D0180-36C24426F0063
Agency244-Network Contract Office 4 (36C244)
Awarding office244-Network Contract Office 4 (36C244)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentNovartis Pharmaceuticals Corp
CAGE04520
UEING61ZA8TADW3
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79720D0180
Place of performanceLEBANON PA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startJan 1, 2026
PoP end (current)Dec 31, 2026
Obligated$2M
Current value$2M
Potential value$2M

RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS is a federal award for 244-Network Contract Office 4 (36C244) held by Novartis Pharmaceuticals Corp. Estimated value $2M ($2M obligated). Current period of performance ends Dec 31, 2026. Last award drew 1 bidder. Place of performance: LEBANON PA.

RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS

Recompete timing

Public
Expiring in 132 days

Current PoP ends Dec 31, 2026 (132 days remaining). Agencies typically plan 12–18 months ahead — at 4.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Novartis Pharmaceuticals Corp$23.5M obligated across 59 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($23.5M) · all agencies
Department of Veterans Affairs (VA)$37.6M · 160%Department of Defense (DOD)$4.7M · 20%
Open full company profile

Related awards

Same parent · incumbent
36C24826F0082
PLUVICTO
$4.7M
Aug 31, 2026
36C25025F0726
PLUVICTO RADIOPHARMACEUTICAL - CLEVELAND VAMC
$400K
Aug 31, 2026
36C24125F0148
PLUVICTO
$810K
Sep 14, 2026
36C26126F0007
PLUVICTO DRUG
$4.0M
Sep 30, 2026
W81K0025FA195
LUTATHERA AND PLUVICTO
$3.2M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24426F0063?

36C24426F0063 (Radiopharmaceuticals-lutathera and pluvicto) is a 244-Network Contract Office 4 (36C244) award with a potential value of $2M, currently held by Novartis Pharmaceuticals Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C244-26-F-0063?

36C244-26-F-0063 is the dashed form of PIID 36C24426F0063 (Radiopharmaceuticals-lutathera and pluvicto), held by Novartis Pharmaceuticals Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24426F0063?

244-Network Contract Office 4 (36C244) awarded 36C24426F0063 to Novartis Pharmaceuticals Corp (potential $2M).

Who is the incumbent on 36C24426F0063?

Novartis Pharmaceuticals Corp is the incumbent with $23.5M across 59 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.

When does Novartis Pharmaceuticals Corp’s 36C24426F0063 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24426F0063